tradingkey.logo

Aura Biosciences Inc <AURA.OQ> expected to post a loss of 49 cents a share - Earnings Preview

ReutersMay 7, 2025 1:09 PM
  • Aura Biosciences Inc AURA.OQ AURA.O is expected to show no change in quarterly revenue when it reports results on May 9 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Aura Biosciences Inc is for a loss of 49 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Aura Biosciences Inc is $22.50​, above​ its last closing price of $5.47. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.45

-0.44

-0.52

Missed

-17.2

Sep. 30 2024

-0.44

-0.44

-0.42

Beat

4.7

Jun. 30 2024

-0.44

-0.45

-0.41

Beat

8.9​

Mar. 31 2024

-0.48

-0.49

-0.40

Beat

17.7

​​Dec. 31 2023

-0.44

-0.41

-0.56

Missed

-35.9

Sep. 30 2023

-0.53

-0.52

-0.48

Beat

7.8​

Jun. 30 2023

-0.49

-0.49

-0.48

Beat

2

Mar. 31 2023

-0.53

-0.54

-0.46

Beat

14.9

This summary was machine generated May 7 at 13:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI